RT @_DanMangan: #mylan faces #SEC probe over #EpiPen rebates AND apparently won’t pay higher #Medicaid rebates until next April 1 cnb.cx/2dGt7pg
<span class="my_class">Piper</span> Report
- Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory Models
- Use of Prescription Medicines Today and Forecasts for 2023: Valuable Market Insights from IQVIA
- Real-World Evidence in Medical Product Development: Drugs, Biologics, Diagnostics, and Devices
- Physician Practice Patterns and Perspectives on Change: Insights from National Survey
- Teen Hospital Stays for Childbirth: Latest National and State Specific Trends
- Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid, Medicare Part D, and Private Health Insurance